Literature DB >> 23243065

Translational control in Plasmodium and toxoplasma parasites.

Min Zhang1, Bradley R Joyce, William J Sullivan, Victor Nussenzweig.   

Abstract

The life cycles of apicomplexan parasites such as Plasmodium spp. and Toxoplasma gondii are complex, consisting of proliferative and latent stages within multiple hosts. Dramatic transformations take place during the cycles, and they demand precise control of gene expression at all levels, including translation. This review focuses on the mechanisms that regulate translational control in Plasmodium and Toxoplasma, with a particular emphasis on the phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α). Phosphorylation of eIF2α (eIF2α∼P) is a conserved mechanism that eukaryotic cells use to repress global protein synthesis while enhancing gene-specific translation of a subset of mRNAs. Elevated levels of eIF2α∼P have been observed during latent stages in both Toxoplasma and Plasmodium, indicating that translational control plays a role in maintaining dormancy. Parasite-specific eIF2α kinases and phosphatases are also required for proper developmental transitions and adaptation to cellular stresses encountered during the life cycle. Identification of small-molecule inhibitors of apicomplexan eIF2α kinases may selectively interfere with parasite translational control and lead to the development of new therapies to treat malaria and toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23243065      PMCID: PMC3571306          DOI: 10.1128/EC.00296-12

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  71 in total

Review 1.  A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages.

Authors:  L H Bannister; J M Hopkins; R E Fowler; S Krishna; G H Mitchell
Journal:  Parasitol Today       Date:  2000-10

2.  Multiple upstream AUG codons mediate translational control of GCN4.

Authors:  P P Mueller; A G Hinnebusch
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

3.  Molecular cloning, characterization and localization of PfPK4, an eIF-2alpha kinase-related enzyme from the malarial parasite Plasmodium falciparum.

Authors:  J J Möhrle; Y Zhao; B Wernli; R M Franklin; B Kappes
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

4.  Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

Authors:  C J Beckers; D S Roos; R G Donald; B J Luft; J C Schwab; Y Cao; K A Joiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Plasmodium falciparum PF10_0164 (ETRAMP10.3) is an essential parasitophorous vacuole and exported protein in blood stages.

Authors:  Drew C Mackellar; Matthew T O'Neill; Ahmed S I Aly; John B Sacci; Alan F Cowman; Stefan H I Kappe
Journal:  Eukaryot Cell       Date:  2010-03-12

6.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Authors:  Ann-Kristin Mueller; Mehdi Labaied; Stefan H I Kappe; Kai Matuschewski
Journal:  Nature       Date:  2004-12-05       Impact factor: 49.962

7.  Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum.

Authors:  Heather J Painter; Joanne M Morrisey; Michael W Mather; Akhil B Vaidya
Journal:  Nature       Date:  2007-03-01       Impact factor: 49.962

8.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

Authors:  Ann-Kristin Mueller; Nelly Camargo; Karine Kaiser; Cathy Andorfer; Ute Frevert; Kai Matuschewski; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

9.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

Review 10.  Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote.

Authors:  Pauline Ward; Leila Equinet; Jeremy Packer; Christian Doerig
Journal:  BMC Genomics       Date:  2004-10-12       Impact factor: 3.969

View more
  24 in total

1.  Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.

Authors:  Anthony P Sinai; Elizabeth A Watts; Animesh Dhara; Robert D Murphy; Matthew S Gentry; Abhijit Patwardhan
Journal:  Curr Clin Microbiol Rep       Date:  2016-10-04

2.  The unfolded protein response in the protozoan parasite Toxoplasma gondii features translational and transcriptional control.

Authors:  Bradley R Joyce; Zoi Tampaki; Kami Kim; Ronald C Wek; William J Sullivan
Journal:  Eukaryot Cell       Date:  2013-05-10

3.  A minimalistic approach to develop new anti-apicomplexa polyamines analogs.

Authors:  Esteban A Panozzo-Zénere; Exequiel O J Porta; Gustavo Arrizabalaga; Lucía Fargnoli; Shabana I Khan; Babu L Tekwani; Guillermo R Labadie
Journal:  Eur J Med Chem       Date:  2017-12-02       Impact factor: 6.514

4.  ALBA4 modulates its stage-specific interactions and specific mRNA fates during Plasmodium yoelii growth and transmission.

Authors:  Elyse E Muñoz; Kevin J Hart; Michael P Walker; Mark F Kennedy; Mackenzie M Shipley; Scott E Lindner
Journal:  Mol Microbiol       Date:  2017-08-29       Impact factor: 3.501

5.  Adaptation of Plasmodium falciparum to its transmission environment.

Authors:  Martin K Rono; Mary A Nyonda; Joan J Simam; Joyce M Ngoi; Sachel Mok; Moses M Kortok; Abdullah S Abdullah; Mohammed M Elfaki; John N Waitumbi; Ibrahim M El-Hassan; Kevin Marsh; Zbynek Bozdech; Margaret J Mackinnon
Journal:  Nat Ecol Evol       Date:  2017-12-18       Impact factor: 15.460

6.  Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.

Authors:  Christian Konrad; Sherry F Queener; Ronald C Wek; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

Review 7.  Illuminating Parasite Protein Production by Ribosome Profiling.

Authors:  Marilyn Parsons; Peter J Myler
Journal:  Trends Parasitol       Date:  2016-04-06

8.  Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis.

Authors:  Imaan Benmerzouga; Lisa A Checkley; Michael T Ferdig; Gustavo Arrizabalaga; Ronald C Wek; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

9.  Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum.

Authors:  Gregory LaMonte; Katelyn A Walzer; Joshua Lacsina; Christopher Nicchitta; Jen-Tsan Chi
Journal:  J Vis Exp       Date:  2015-12-04       Impact factor: 1.355

10.  Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency.

Authors:  Min Zhang; Julio Gallego-Delgado; Cristina Fernandez-Arias; Norman C Waters; Ana Rodriguez; Moriya Tsuji; Ronald C Wek; Victor Nussenzweig; William J Sullivan
Journal:  Cell Host Microbe       Date:  2017-12-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.